vs
华钦科技（CLPS）与Tarsus Pharmaceuticals, Inc.（TARS）财务数据对比。点击上方公司名可切换其他公司
Tarsus Pharmaceuticals, Inc.的季度营收约是华钦科技的1.8倍（$151.7M vs $82.8M），华钦科技净利率更高（0.2% vs -5.5%，领先5.7%）
华钦科技（CLPS Inc）是全球领先的信息技术咨询与数字化解决方案服务商，核心服务银行、保险、资产管理等金融领域客户，同时覆盖零售、医疗健康、电商等行业，业务遍及北美、亚太及欧洲地区。
Tarsus Pharmaceuticals是一家处于后期临床阶段的生物制药公司，专注于眼科、皮肤科等专科领域创新疗法的研发和商业化，主打产品针对蠕形螨睑缘炎、玫瑰痤疮等未被充分诊断的常见病症，核心市场为美国。
CLPS vs TARS — 直观对比
营收规模更大
TARS
是对方的1.8倍
$82.8M
净利率更高
CLPS
高出5.7%
-5.5%
损益表 — Q4 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $82.8M | $151.7M |
| 净利润 | $183.0K | $-8.4M |
| 毛利率 | 23.1% | — |
| 营业利润率 | 0.2% | -5.3% |
| 净利率 | 0.2% | -5.5% |
| 营收同比 | — | 128.4% |
| 净利润同比 | — | 63.8% |
| 每股收益（稀释后） | — | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLPSTARS
| Q2 26 | $82.8M | — | ||
| Q4 25 | — | $151.7M | ||
| Q3 25 | — | $118.7M | ||
| Q2 25 | — | $102.7M | ||
| Q1 25 | — | $78.3M | ||
| Q4 24 | $71.8M | $66.4M | ||
| Q3 24 | — | $48.1M | ||
| Q2 24 | — | $40.8M |
净利润CLPSTARS
| Q2 26 | $183.0K | — | ||
| Q4 25 | — | $-8.4M | ||
| Q3 25 | — | $-12.6M | ||
| Q2 25 | — | $-20.3M | ||
| Q1 25 | — | $-25.1M | ||
| Q4 24 | $-993.5K | $-23.1M | ||
| Q3 24 | — | $-23.4M | ||
| Q2 24 | — | $-33.3M |
毛利率CLPSTARS
| Q2 26 | 23.1% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 21.9% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
营业利润率CLPSTARS
| Q2 26 | 0.2% | — | ||
| Q4 25 | — | -5.3% | ||
| Q3 25 | — | -12.2% | ||
| Q2 25 | — | -21.6% | ||
| Q1 25 | — | -33.5% | ||
| Q4 24 | -1.3% | -36.8% | ||
| Q3 24 | — | -52.3% | ||
| Q2 24 | — | -81.6% |
净利率CLPSTARS
| Q2 26 | 0.2% | — | ||
| Q4 25 | — | -5.5% | ||
| Q3 25 | — | -10.6% | ||
| Q2 25 | — | -19.8% | ||
| Q1 25 | — | -32.1% | ||
| Q4 24 | -1.4% | -34.8% | ||
| Q3 24 | — | -48.7% | ||
| Q2 24 | — | -81.6% |
每股收益（稀释后）CLPSTARS
| Q2 26 | — | — | ||
| Q4 25 | — | $-0.17 | ||
| Q3 25 | — | $-0.30 | ||
| Q2 25 | — | $-0.48 | ||
| Q1 25 | — | $-0.64 | ||
| Q4 24 | — | $-0.57 | ||
| Q3 24 | — | $-0.61 | ||
| Q2 24 | — | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $29.1M | $417.3M |
| 总债务越低越好 | — | $72.4M |
| 股东权益账面价值 | $57.6M | $343.4M |
| 总资产 | $118.1M | $562.2M |
| 负债/权益比越低杠杆越低 | — | 0.21× |
8季度趋势，按日历期对齐
现金及短期投资CLPSTARS
| Q2 26 | $29.1M | — | ||
| Q4 25 | — | $417.3M | ||
| Q3 25 | — | $401.8M | ||
| Q2 25 | — | $381.1M | ||
| Q1 25 | — | $407.9M | ||
| Q4 24 | $31.2M | $291.4M | ||
| Q3 24 | — | $317.0M | ||
| Q2 24 | — | $323.6M |
总债务CLPSTARS
| Q2 26 | — | — | ||
| Q4 25 | — | $72.4M | ||
| Q3 25 | — | $72.3M | ||
| Q2 25 | — | $72.1M | ||
| Q1 25 | — | $72.0M | ||
| Q4 24 | — | $71.8M | ||
| Q3 24 | — | $71.7M | ||
| Q2 24 | — | $71.6M |
股东权益CLPSTARS
| Q2 26 | $57.6M | — | ||
| Q4 25 | — | $343.4M | ||
| Q3 25 | — | $335.1M | ||
| Q2 25 | — | $332.6M | ||
| Q1 25 | — | $342.5M | ||
| Q4 24 | $63.9M | $224.5M | ||
| Q3 24 | — | $237.5M | ||
| Q2 24 | — | $252.2M |
总资产CLPSTARS
| Q2 26 | $118.1M | — | ||
| Q4 25 | — | $562.2M | ||
| Q3 25 | — | $534.6M | ||
| Q2 25 | — | $495.0M | ||
| Q1 25 | — | $500.8M | ||
| Q4 24 | $110.0M | $377.0M | ||
| Q3 24 | — | $376.3M | ||
| Q2 24 | — | $376.8M |
负债/权益比CLPSTARS
| Q2 26 | — | — | ||
| Q4 25 | — | 0.21× | ||
| Q3 25 | — | 0.22× | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.30× | ||
| Q2 24 | — | 0.28× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $19.3M |
| 自由现金流经营现金流 - 资本支出 | — | $13.0M |
| 自由现金流率自由现金流/营收 | — | 8.6% |
| 资本支出强度资本支出/营收 | — | 4.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-22.3M |
8季度趋势，按日历期对齐
经营现金流CLPSTARS
| Q2 26 | — | — | ||
| Q4 25 | — | $19.3M | ||
| Q3 25 | — | $18.3M | ||
| Q2 25 | — | $-29.4M | ||
| Q1 25 | — | $-20.7M | ||
| Q4 24 | — | $-22.2M | ||
| Q3 24 | — | $-8.7M | ||
| Q2 24 | — | $-14.4M |
自由现金流CLPSTARS
| Q2 26 | — | — | ||
| Q4 25 | — | $13.0M | ||
| Q3 25 | — | $16.3M | ||
| Q2 25 | — | $-30.4M | ||
| Q1 25 | — | $-21.2M | ||
| Q4 24 | — | $-22.3M | ||
| Q3 24 | — | $-8.9M | ||
| Q2 24 | — | $-15.4M |
自由现金流率CLPSTARS
| Q2 26 | — | — | ||
| Q4 25 | — | 8.6% | ||
| Q3 25 | — | 13.8% | ||
| Q2 25 | — | -29.6% | ||
| Q1 25 | — | -27.1% | ||
| Q4 24 | — | -33.5% | ||
| Q3 24 | — | -18.6% | ||
| Q2 24 | — | -37.8% |
资本支出强度CLPSTARS
| Q2 26 | — | — | ||
| Q4 25 | — | 4.2% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 2.5% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
